Procept BioRobotics
(NASDAQ) PRCT
Procept BioRobotics Financials at a Glance
Market Cap
$1.21BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$322.02M
Net Income (TTM)
-$102.47M
EPS (TTM)
-$1.83
P/E Ratio
-11.59
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$21.08
Volume
1,449,217.798
Open
$21.39
Price
$21.08
Volume
1,449,217.798
Open
$21.39
Previous Close
$21.03
Daily Range
$20.26 - $21.72
52-Week Range
$19.35 - $62.17
Estimated Earnings Date
Aug 5, 2026
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$21.08
Volume
1,449,217.798
Open
$21.39
Previous Close
$21.03
Daily Range
$20.26 - $21.72
52-Week Range
$19.35 - $62.17
Estimated Earnings Date
Aug 5, 2026
PRCT News
PRCT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Procept BioRobotics
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
888
CEO
Larry L. Wood, MBA
Website
www.procept-biorobotics.comHeadquarters
San Jose, CA 94065, US
PRCT Financials
Key Financial Metrics (TTM)
Gross Margin
62.98%
Operating Margin
-33.86%
Net Income Margin
-31.82%
Return on Equity
-27.70%
Return on Capital
-24.88%
Return on Assets
-21.04%
Earnings Yield
-8.63%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.21BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
56.92M
Volume
1.45M
Avg. Volume
1.55M
Financials (TTM)
Gross Profit
$202.81M
Operating Income
-$109.03M
EBITDA
-$92.11M
Operating Cash Flow
-$70.13M
Capital Expenditure
-$10.43M
Free Cash Flow
-$80.57M
Cash & ST Invst.
$245.64M
Total Debt
$51.66M
Procept BioRobotics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$83.13M
+20.2%
Gross Profit
$53.95M
+22.2%
Gross Margin
64.89%
N/A
Market Cap
$1.21BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$1.60M
N/A
Employees
756
N/A
Net Income
-$31.64M
-27.9%
EBITDA
-$29.09M
-29.9%
Quarterly Fundamentals
Total Cash
$245.64M
-22.3%
Total Debt
$51.66M
-35.3%
Accounts Receivable
$96.39M
+21.6%
Inventory
$77.54M
+24.4%
Long Term Debt
$51.66M
-33.6%
Short Term Debt
$0.00
-100.0%
Return on Assets
-21.04%
N/A
Return on Invested Capital
-25.75%
N/A
Free Cash Flow
-$41.04M
-118.1%
Operating Cash Flow
-$38.13M
-124.5%